Published in BMC Cancer on May 29, 2006
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Mol Cancer (2010) 1.30
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol (2011) 1.20
The bladder extracellular matrix. Part I: architecture, development and disease. Nat Rev Urol (2009) 1.19
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer. Br J Cancer (2010) 1.15
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol (2008) 1.08
Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci (2013) 0.91
Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med (2012) 0.85
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clin Cancer Res (2012) 0.85
Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression. BMC Urol (2012) 0.83
Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract. BMC Cancer (2012) 0.80
The role of structural extracellular matrix proteins in urothelial bladder cancer (review). Biomark Insights (2007) 0.77
Role of angiogenesis in urothelial bladder carcinoma. Cent European J Urol (2016) 0.75
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (1994) 5.54
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med (2000) 5.05
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol (1993) 3.15
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol (1990) 2.69
How tumors become angiogenic. Adv Cancer Res (1996) 2.63
Tenascin interferes with fibronectin action. Cell (1988) 2.60
Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol (1988) 2.41
Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood (1997) 2.15
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol (1999) 2.11
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst (1995) 2.10
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A (1999) 2.01
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A (1991) 1.94
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer (2002) 1.68
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer (1994) 1.57
Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem (1993) 1.56
Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol (1987) 1.56
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene (1997) 1.47
Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J Biol Chem (1996) 1.46
Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol (1994) 1.45
Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst (1997) 1.45
Thrombospondin promotes cell-substratum adhesion. Science (1987) 1.44
Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol (1988) 1.29
Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res (1998) 1.24
Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol (1995) 1.22
Molecular mediators of angiogenesis in bladder cancer. Cancer Res (1998) 1.20
Colocalization of thrombospondin and syndecan during murine development. Dev Dyn (1992) 1.17
Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest (1995) 1.16
Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res (1982) 1.14
Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol (1993) 1.13
Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology (1998) 1.10
Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer (1999) 1.09
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. J Exp Med (2000) 1.07
The response of endothelial cells to TGF beta-1 is dependent upon cell shape, proliferative state and the nature of the substratum. J Cell Sci (1991) 1.02
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci (1995) 1.01
The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim Biophys Acta (1993) 0.98
Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast. Cell Differ Dev (1990) 0.97
Tumor cell adhesive mechanisms and their relationship to metastasis. Semin Cancer Biol (1991) 0.94
Thrombospondin as a mediator of cancer cell adhesion in metastasis. Cancer Metastasis Rev (1992) 0.92
Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin Cancer Res (1999) 0.91
A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int (2005) 0.90
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder. J Pathol (2002) 0.90
Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. J Cell Physiol (1994) 0.88
Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer. Eur Urol (2002) 0.88
Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis. Oncology (2001) 0.87
Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.85
Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci (1993) 0.85
Thrombospondin as a regulator of angiogenesis. EXS (1997) 0.82
The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer. J Urol (2001) 0.81
Intravesical instillations of interferon gamma in the prophylaxis of high risk superficial bladder cancer--results of a controlled prospective study. Scand J Urol Nephrol (2002) 0.78
Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder. J Urol (1997) 0.77
Hypoxia and angiogenesis in experimental tumor models: therapeutic implications. EXS (1997) 0.77
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev (2009) 1.82
Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol (2001) 1.60
Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye (Lond) (2006) 1.12
The presence of proprioceptive mechanoreceptors in the remnants of the ruptured ACL as a possible source of re-innervation of the ACL autograft. Knee Surg Sports Traumatol Arthrosc (2001) 1.11
Multifocal glioblastoma with remote cutaneous metastasis: a case report and review of the literature. Cent Eur Neurosurg (2009) 0.96
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histol Histopathol (2004) 0.96
Evaluation of claspin as a proliferation marker in human cancer and normal tissues. J Pathol (2007) 0.95
Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas. Mod Pathol (2003) 0.95
E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol (2007) 0.90
Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic? Eur Respir J (1996) 0.89
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. Int J Gynecol Cancer (2006) 0.88
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. J Exp Clin Cancer Res (2004) 0.88
Follicular thyroid cancer metastasis to the urinary bladder: report of a case and review of the literature. Case Rep Urol (2012) 0.88
Bilateral papillary renal cell carcinoma. Eur Radiol (2001) 0.88
High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Gynecol Oncol (2010) 0.87
Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy. Eur J Ophthalmol (2005) 0.86
Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res (2001) 0.86
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins. Urol Int (2006) 0.86
Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis (1994) 0.86
Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol (2003) 0.85
Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit. J Cancer Res Clin Oncol (2007) 0.85
Is expansion of artificial dermis a reliable reconstructive option? Ann Burns Fire Disasters (2011) 0.83
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer. Breast (2003) 0.82
Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery. Surg Endosc (2001) 0.81
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol (2001) 0.81
Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J Exp Clin Cancer Res (2004) 0.81
The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules. In Vivo (2005) 0.81
Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. Histol Histopathol (2012) 0.81
Transvaginal uterine ultrasonography compared with endometrial biopsy for the detection of endometrial disease in perimenopausal women with uterine bleeding. Anticancer Res (2002) 0.80
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions. Histol Histopathol (2006) 0.80
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases. Ann Oncol (2012) 0.80
Simultaneous adenomectomy and preperitoneal repair of inguinal hernias by a single incision with the application of polypropylene mesh. Int Urol Nephrol (2003) 0.79
Randomised comparison of growth hormone versus IGF-1 on early post-myocardial infarction ventricular remodelling in rats. Growth Horm IGF Res (2007) 0.79
Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins. In Vivo (2005) 0.79
Expression of adhesion molecules during normal pregnancy. Cell Tissue Res (2007) 0.78
Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience. Anticancer Res (2001) 0.78
Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1). Eur J Gynaecol Oncol (2003) 0.77
Thermal tissue damage following laser and large loop conization of the cervix. Obstet Gynecol (1994) 0.77
Prostate cancer epidemiology in a rural area of North Western Greece. Asian Pac J Cancer Prev (2012) 0.77
Amiodarone attenuates apoptosis, but induces phospholipidosis in rat alveolar epithelial cells. J Physiol Pharmacol (2010) 0.77
Depression, hopelessness, and suicidal behavior in Chinese and American psychiatric patients. Am J Psychiatry (1989) 0.77
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma. Histol Histopathol (2000) 0.77
Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices. Anticancer Res (2001) 0.77
Oxidative stress based-biomarkers in oral carcinogenesis: how far have we gone? Curr Mol Med (2012) 0.76
HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections. J Pathol (1994) 0.76
Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma. Int Urol Nephrol (2005) 0.76
Anger, hostility, and depression in assaultive vs. suicide-attempting males. J Clin Psychol (1989) 0.76
Successful conservative treatment of catamenial pneumothorax with GnRH agonist. Arch Gynecol Obstet (1995) 0.75
Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices. Int J Gynecol Cancer (2003) 0.75
[Our experience with parotid cysts]. Rev Stomatol Chir Maxillofac (1995) 0.75
Counseling parents of handicapped children. Ohio State Med J (1985) 0.75
Spontaneous evolution of human papillomavirus infection in the uterine cervix. Anticancer Res (2000) 0.75
External beam irradiation following balloon angioplasty in an atherosclerotic rabbit model. Cardiovasc Radiat Med (2001) 0.75
Patient reactions to a no smoking policy in a community mental health center. Community Ment Health J (1989) 0.75
External beam irradiation in angioplasted arteries of hypercholesterolemic rabbits. The dose and time effect. Cardiovasc Radiat Med (2002) 0.75
Deposition of ciprofloxacin, prednisolone phosphate, and prednisolone acetate in SeeQuence disposable contact lenses. CLAO J (1993) 0.75
An observational study of women with positive HPV-DNA tests and normal cytology and colposcopy. Eur J Gynaecol Oncol (2002) 0.75
Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing. Gynecol Oncol (2001) 0.75
Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas. Histol Histopathol (2003) 0.75
Use of the adolescent peer group to increase the self-care agency of adolescent alcohol abusers. Nurs Clin North Am (1980) 0.75
Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases. Lung Cancer (2010) 0.75
Immunohistochemical prognostic markers in bladder cancer. J BUON (2007) 0.75
A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer. Neoplasma (2010) 0.75
Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient? J BUON (2008) 0.75
Distribution of CD1a-positive Langerhans cells and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections. J Pathol (1995) 0.75
Intestinal-type metaplasia in the original squamous epithelium of the cervix. Eur J Gynaecol Oncol (2010) 0.75
Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm IGF Res (2006) 0.75
Using and interpreting item analysis data. Nurse Educ (1986) 0.75
[Capillary hemangioma of the nasal cavity. Apropos of a case]. Rev Stomatol Chir Maxillofac (1993) 0.75
Screening transvaginal uterine ultrasonography for identifying endometrial pathology in postmenopausal women. Anticancer Res (2002) 0.75
Screening transvaginal uterine ultrasonography for identifying endometrial pathology in postmenopausal women. Anticancer Res (2002) 0.75
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study. Lung Cancer (1994) 0.75
Tumor markers in stage P1 bladder cancer. Anticancer Res (2001) 0.75